Karim Solangi

528 total citations
17 papers, 393 citations indexed

About

Karim Solangi is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Karim Solangi has authored 17 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Karim Solangi's work include Pharmacogenetics and Drug Metabolism (4 papers), Erythrocyte Function and Pathophysiology (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Karim Solangi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Erythrocyte Function and Pathophysiology (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Karim Solangi collaborates with scholars based in United States, Pakistan and France. Karim Solangi's co-authors include Alvin I. Goodman, Nader G. Abraham, Pavel Martásek, Michal L. Schwartzman, Richard D. Levere, R D Levere, Stephen A. Weseley, Rakesh Abbi, Ira M. Ventry and S. Adler and has published in prestigious journals such as New England Journal of Medicine, American Journal of Clinical Nutrition and Radiology.

In The Last Decade

Karim Solangi

17 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karim Solangi United States	10	118	87	76	67	57	17	393
J.W. Hinman United States	9	98 0.8×	100 1.1×	69 0.9×	22 0.3×	35 0.6×	10	450
Cumhur Bilgi Türkiye	15	98 0.8×	23 0.3×	88 1.2×	56 0.8×	25 0.4×	32	593
Michiel P. C. Siroen Netherlands	12	97 0.8×	104 1.2×	71 0.9×	45 0.7×	10 0.2×	20	706
P. Speckart United States	8	125 1.1×	137 1.6×	78 1.0×	20 0.3×	100 1.8×	9	589
Ahmad A. Attallah United States	13	80 0.7×	111 1.3×	65 0.9×	21 0.3×	58 1.0×	26	386
J. K. McKenzie Canada	12	173 1.5×	27 0.3×	76 1.0×	55 0.8×	14 0.2×	24	586
Zuhal Parıldar Türkiye	14	116 1.0×	32 0.4×	77 1.0×	37 0.6×	12 0.2×	32	569
Henry Yu United States	6	54 0.5×	22 0.3×	64 0.8×	28 0.4×	52 0.9×	8	478
Ayami Kajiwara Japan	14	76 0.6×	53 0.6×	32 0.4×	38 0.6×	24 0.4×	26	457
Michael N. Hartnett United States	7	114 1.0×	13 0.1×	70 0.9×	37 0.6×	60 1.1×	9	453

Countries citing papers authored by Karim Solangi

Since Specialization

Citations

This map shows the geographic impact of Karim Solangi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Solangi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Solangi more than expected).

Fields of papers citing papers by Karim Solangi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Solangi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Solangi. The network helps show where Karim Solangi may publish in the future.

Co-authorship network of co-authors of Karim Solangi

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Solangi. A scholar is included among the top collaborators of Karim Solangi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Solangi. Karim Solangi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Chiao, Jen Wei, Maxime Melikian, Liying Han, et al.. (2015). Interaction of a small molecule Natura-α and STAT3-SH2 domain to block Y705 phosphorylation and inhibit lupus nephritis. Biochemical Pharmacology. 99. 123–131. 6 indexed citations

Solangi, Karim, et al.. (2008). Acute renal failure in pregnancy: one year observational study at Liaquat University Hospital, Hyderabad.. PubMed. 58(2). 61–4. 53 indexed citations

Solangi, Karim, et al.. (1997). Nephrotic syndrome, renal failure, and renal malignancy. Journal of the American Society of Nephrology. 8(5). 848–852. 27 indexed citations

Martásek, Pavel, Michal L. Schwartzman, Alvin I. Goodman, et al.. (1991). Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats.. Journal of the American Society of Nephrology. 2(6). 1078–1084. 59 indexed citations

Schwartzman, Michal L., Pavel Martásek, Richard D. Levere, et al.. (1990). Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney International. 37(1). 94–99. 82 indexed citations

Solangi, Karim, David Sacerdoti, Alvin I. Goodman, et al.. (1988). Differential Effects of Partial Hepatectomy on Hepatic and Renal Heme and Cytochrome P450 Metabolism. The American Journal of the Medical Sciences. 296(6). 387–391. 22 indexed citations

Solangi, Karim, et al.. (1988). Isolation and Purification of Erythropoiesis Inhibitory Activity from Uremic Sera. The Nephron journals/Nephron journals. 48(1). 22–27. 2 indexed citations

Martásek, Pavel, et al.. (1988). Properties of human kidney heme oxygenase: Inhibition by synthetic heme analogues and metalloporphyrins. Biochemical and Biophysical Research Communications. 157(2). 480–487. 23 indexed citations

Stea, Susanna, David Sacerdoti, M L Schwartzman, et al.. (1987). Differential effects of hepatectomy on renal heme dependent drug metabolism. Clinical research. 35(3). 415. 1 indexed citations

10.

Solangi, Karim, et al.. (1987). Development of a cytochrome P-450 monooxygenase system in clonogenic hemopoietic cells.. PubMed. 56(1). 87–99. 4 indexed citations

11.

Solangi, Karim, et al.. (1985). Pharmacologic Toxicity of Cimetidine on Hepatic and Renal Drug Metabolism. The Journal of Urology. 133(4). 740–740. 3 indexed citations

12.

Lutton, J. D., et al.. (1984). Inhibition of Erythropoiesis in Chronic Renal Failure: The Role of Parathyroid Hormone. American Journal of Kidney Diseases. 3(5). 380–384. 6 indexed citations

13.

Solangi, Karim, et al.. (1981). Hearing impairment associated with chronic renal failure. The Laryngoscope. 91(4). 583–592. 33 indexed citations

14.

Adler, Jonathan, et al.. (1978). Gelfoam Embolization of the Kidneys for Treatment of Malignant Hypertension. Radiology. 128(1). 45–48. 18 indexed citations

15.

Solangi, Karim, et al.. (1975). Hypertriglyceridemia in patients with chronic renal insufficiency. American Journal of Clinical Nutrition. 28(9). 1036–1043. 27 indexed citations

16.

Corey, Lawrence, Walter E. Stamm, Paul M. Feorino, et al.. (1975). HB_sAg-Negative Hepatitis in a Hemodialysis Unit. New England Journal of Medicine. 293(25). 1273–1278. 22 indexed citations

17.

Solangi, Karim, et al.. (1975). Hypertriglyceridemia in patients with chronic renal insufficiency. Am J Clin Nutr 28:1036-1043. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact